Yarbrough Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,399
| Closed | -$331K | – | 198 |
|
|
2024
Q4 | $331K | Hold |
8,399
| – | – | 0.01% | 161 |
|
|
2024
Q3 | $395K | Hold |
8,399
| – | – | 0.02% | 155 |
|
|
2024
Q2 | $454K | Sell |
8,399
-100
| -1% | -$5.4K | 0.02% | 134 |
|
|
2024
Q1 | $579K | Hold |
8,499
| – | – | 0.03% | 120 |
|
|
2023
Q4 | $532K | Hold |
8,499
| – | – | 0.03% | 123 |
|
|
2023
Q3 | $386K | Hold |
8,499
| – | – | 0.02% | 149 |
|
|
2023
Q2 | $477K | Hold |
8,499
| – | – | 0.03% | 139 |
|
|
2023
Q1 | $384K | Buy |
8,499
+8,399
| +8,399% | +$380K | 0.03% | 153 |
|
|
2022
Q4 | $4.07K | Buy |
+100
| New | +$4.07K | ﹤0.01% | 218 |
|
|
2022
Q1 | – | Sell |
-24,100
| Closed | -$1.83M | – | 213 |
|
|
2021
Q4 | $1.83M | Buy |
+24,100
| New | +$1.83M | 0.1% | 86 |
|